Results 151 to 160 of about 4,028,254 (313)

Deep caries management: EFCD-ESE-ORCA S3-level clinical practice guideline. [PDF]

Clin Oral Investig
Schwendicke F, Kosan E, Banerjee A, Baysan A, Bjørndal L, Ceballos L, Duncan HF, Herbst S, Neuhaus KW, O'Connell AC, Paris S, Dujic H.   +11 more
europepmc   +2 more sources

A consensus exercise to inform the future of National Health Service General Dental Services using a modified-Delphi technique. [PDF]

Br Dent J
Chestnutt IG, Pattinson R, Brocklehurst P, Cope AL.   +3 more
europepmc   +1 more source

Treatment of Chronic Viral Hepatitis with Alpha-Inferon: A Consensus Conference Report

Canadian Journal of Gastroenterology, 1994
The CASL Hepatitis Consensus Group
doaj   +1 more source

Sequencing complete plasmids on Oxford Nanopore Technologies sequencers using R2C2 and Chopper. [PDF]

PLoS One
Schimke KD, Vollmers C.
europepmc   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

Multi-adaptive event-triggered consensus of positive multi-agent systems using pinning strategy. [PDF]

PLoS One
Li Q, Dong L, Yang H.
europepmc   +1 more source

Confessional Perspectives on the Church for Today (Part 2) [PDF]

, 1976
Schoenheider, Robert G.
core   +2 more sources

The Renal Activity Index for Lupus Identifies Active Renal Disease and Treatment Response in Adult Patients With Systemic Lupus Erythematosus and Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective We evaluated the ability of the Renal Activity Index for Lupus (RAIL) to discriminate active lupus nephritis (LN) in adult patients with active systemic lupus erythematosus (SLE) and differentiate LN treatment response. Methods Urine samples from adults with biopsy‐proven active class III and IV LN from TULIP‐LN (active LN group ...
Hermine I. Brunner, Ellen M. Cody, Prasad Devarajan, Bin Huang, Chen Chen, Dominic Sinibaldi, Madhu Ramaswamy, Jacob Knagenhjelm, Frederick Jones, Philip Z. Brohawn, Raj Tummala, Catharina Lindholm, Wendy I. White   +12 more
wiley   +1 more source

Expert-recommended tasks for hospital librarians during a healthcare system merger or acquisition: an e-Delphi consensus statement. [PDF]

J Med Libr Assoc
Posillico S, Morales J, Herman SW.
europepmc   +1 more source

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and 1‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

Arthritis Care &Research, EarlyView.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension phase).
Fabrizio De Benedetti, Inmaculada C. Penadés, Irina Nikishina, Ivan Foeldvari, Alberto J. Spindler, Anna Kozlova, Nadina Rubio‐Pérez, Pierre Quartier, Zbigniew Żuber, Raul Barria, Daniel Clemente, Gabriel V. Cornejo, Katherine Marzan, Nancy Liu, Christine Xu, Stephen DiMartino, Angeliki Giannelou, Fei Cao‐Ghoul, Bolanle Akinlade, Lydie Baret‐Cormel   +19 more
wiley   +1 more source